Zeeshan Ahmed Khattak: Why Every Pharmacist Should Consider an Anticoagulation Certification
Zeeshan Ahmed Khattak, Pharmacist (IP/Oncology) at Abu Dhabi Stem Cells Center, shared on LinkedIn:
”Why Every Pharmacist Should Consider an Anticoagulation Certification
Anticoagulants are among the highest-risk medications in clinical practice.
Specialized Anticoagulation Certification empowers pharmacists to play a critical role in ensuring safe, effective, and evidence-based therapy.
Key Benefits for Pharmacists
- Enhanced knowledge of warfarin, DOACs, and parenteral anticoagulants
- Improved skills in dose adjustment, monitoring, and bleeding risk management
- Stronger collaboration with physicians in anticoagulation clinics
- Reduced medication errors and improved patient outcomes
- Career advancement in clinical pharmacy, cardiology, hematology, and ambulatory care
Trusted References and Evidence-Based Sources
• ACCP Antithrombotic Therapy Guidelines
• American Heart Association (AHA)
• American College of Cardiology (ACC)
• CHEST Guidelines on Antithrombotic Therapy
• ISTH (International Society on Thrombosis and Haemostasis)
Recognized Anticoagulation Certifications
• Certified Anticoagulation Care Provider (CACP) – National Certification Board for Anticoagulation Providers
• Anticoagulation Therapy Certificate Program – ACCP
• ASHP Anticoagulation Management Resources
In today’s evolving healthcare landscape, pharmacist-led anticoagulation management is no longer optional—it’s essential.
Investing in anticoagulation certification means safer patients, stronger clinical impact, and professional growth.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs